These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 12153918)

  • 1. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy. A follow up study].
    Ulrich LS; Wells M; Sturdee DW; Barlow DH; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    Ugeskr Laeger; 2003 Sep; 165(37):3530-2. PubMed ID: 14531356
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
    Archer DF; Furst K; Tipping D; Dain MP; Vandepol C
    Obstet Gynecol; 1999 Oct; 94(4):498-503. PubMed ID: 10511348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate.
    Iatrakis G; Tsionis C; Antoniadis S; Kourounis G
    Clin Exp Obstet Gynecol; 2004; 31(1):50-2. PubMed ID: 14998189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
    Koninckx PR; Spielmann D
    Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
    Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
    Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group.
    Bjarnason K; Cerin A; Lindgren R; Weber T
    Maturitas; 1999 Aug; 32(3):161-70. PubMed ID: 10515673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
    Brynhildsen J; Hammar M
    Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer after combined hormone replacement therapy.
    Gruber DM; Wagner G; Kurz C; Sator MO; Huber JC
    Maturitas; 1999 Mar; 31(3):237-40. PubMed ID: 10340283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
    Neven P; Lunde T; Benedetti-Panici P; Tiitinen A; Marinescu B; de Villiers T; Hillard T; Cano A; Peer E; Quail D; Nickelsen T;
    BJOG; 2003 Feb; 110(2):157-67. PubMed ID: 12618160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Gräser T; Koytchev R; Müller A; Oettel M
    Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.